Recursion (RXRX) Jumps 8% on Bargain-Hunting

Group 1 - Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) experienced a significant stock increase of 8.31% on Friday, closing at $4.17 after a previous drop to the $3 level [1][2] - The stock's performance was influenced by a broader market rally, driven by rising hopes for an interest rate cut following dovish comments from Federal Reserve Bank of New York President John Williams [2][3] - Williams indicated that monetary policy is "modestly restrictive" and suggested potential adjustments to the federal funds rate to align closer to neutral [3] Group 2 - Despite the stock's rise, Recursion Pharmaceuticals reported disappointing third-quarter earnings, with a net loss that widened by 69% to $162 million compared to $95.8 million in the same period last year [4] - The company's revenues fell sharply by 80% to $5.17 million from $26.08 million year-on-year [4][5] - There is a belief that while RXRX has potential, other AI stocks may offer better returns with limited downside risk [5]